"Designing Growth Strategies is in our DNA"

Human Papillomavirus (HPV) Vaccine Market Size, Share & COVID-19 Impact Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI101962

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis
    2. Technological Advancements in the Human Papillomavirus Vaccine Market
    3. Regulatory Scenario -  For Key Countries, 2019
    4. Prevalence of Cervical Cancer -  For Key Countries, 2019
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. GlaxoSmithKline plc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Merck & Co., Inc
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations

List of Tables

Table 1:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016–2027

Table 2:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016–2027

Table 3:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016–2027

Table 4:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Region, 2016-2027

Table 5:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 6:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 7:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 8:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country, 2016-2027

Table 9:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 10:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 11:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 12:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 14:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 15:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 16:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 18:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 19:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 22:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 23:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 24:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

List of Figures

Figure 1:  Global Human Papillomavirus Vaccine Market Revenue Breakdown (USD Bn, %) by Region, 2019 & 2027

Figure 2:  Global Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019 & 2027

Figure 3:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Bivalent, 2016-2027

Figure 4:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Polyvalent, 2016-2027

Figure 5:  Global Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 6:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by HPV Associated Cancer, 2016-2027

Figure 7:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Genital Warts, 2016-2027

Figure 8:  Global Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 9:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Hospital & Retail Pharmacies, 2016-2027

Figure 10:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Government Suppliers, 2016-2027

Figure 11:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Others, 2016-2027

Figure 12:  Global Human Papillomavirus Vaccine Market Value (USD Bn), by Region, 2019 & 2027

Figure 13:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 14:  North America Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 15:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 16:  North America Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 17:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 18:  North America Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 19:  North America Human Papillomavirus Vaccine Market Value (USD Bn), By Country, 2019 & 2027

Figure 20:  North America Human Papillomavirus Vaccine Market Value Share (%), By Country, 2019

Figure 21:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 22:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 23:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 24:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 25:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 26:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 27:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 28:  Europe Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 29:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 30:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 31:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 32:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 33:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 34:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 35:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 36:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 37:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 38:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 39:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 40:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 41:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 42:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 43:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 44:  Latin America Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 45:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 46:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 47:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 48:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 49:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 50:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 51:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 52:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 53:  Global Human Papillomavirus Vaccine Market Share (%), By Company, 2019

 class=
  • Aug, 2020
  • 2019
  • 2016-2018
  • 132

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X